Patents by Inventor Dorothy McCabe

Dorothy McCabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating anemia by administering IL-1ra
    Patent number: 7867481
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Grant
    Filed: December 22, 2004
    Date of Patent: January 11, 2011
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia
  • METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
    Publication number: 20100303815
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Application
    Filed: May 28, 2010
    Publication date: December 2, 2010
    Applicant: Amgen Inc.
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia
  • Method of treating anemia by administering IL-1ra
    Patent number: 7087224
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: August 8, 2006
    Assignee: Amgen Inc.
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia
  • Method of treating blood disorders
    Publication number: 20050106148
    Abstract: The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Application
    Filed: December 22, 2004
    Publication date: May 19, 2005
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco Coccia
  • Method of treating blood disorders
    Publication number: 20020077294
    Abstract: The invention relates to methods of treating a blood disorder in a mammmal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.
    Type: Application
    Filed: October 2, 2001
    Publication date: June 20, 2002
    Applicant: Amgen Inc.
    Inventors: Jonathan Kay, Dorothy McCabe, Richard Newmark, Marco A. Coccia